News from ACC.25: SOUL, oral semaglutide reduces MACE in T2D

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
ACC.25 – Gina Lundberg gives her reaction to the recently presented study findings from SOUL with oral semaglutide in high-risk T2D.
Educational information
This video was recorded during the ACC.25 Scientific Session Chicago, IL, USA.
Faculty
Gina Price Lundberg is a cardiologist at Emory Clinic in East Cobb and at Emory Saint Joseph Women's Center in Atlanta, GA, USA. She is associate professor at Emory University and clinical director of the Emory Womens Cardiovascular Health Center. She is chair of the ACC Women in Cardiology (WIC) Leadership Council and a member of the AHA Clinical Cardiology Leadership Council.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 18 April 2025
Read our summary of the SOUL trial
The findings of this study were simultaneously published in N Engl J Med.
The information and data provided in this program were updated and correct at the time of its development, but may be subject to change.

Recommended

Details

Presenters

Overview
ACC.25 – Gina Lundberg gives her reaction to the recently presented study findings from SOUL with oral semaglutide in high-risk T2D.
Educational information
This video was recorded during the ACC.25 Scientific Session Chicago, IL, USA.
Faculty
Gina Price Lundberg is a cardiologist at Emory Clinic in East Cobb and at Emory Saint Joseph Women's Center in Atlanta, GA, USA. She is associate professor at Emory University and clinical director of the Emory Womens Cardiovascular Health Center. She is chair of the ACC Women in Cardiology (WIC) Leadership Council and a member of the AHA Clinical Cardiology Leadership Council.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 18 April 2025
Read our summary of the SOUL trial
The findings of this study were simultaneously published in N Engl J Med.
The information and data provided in this program were updated and correct at the time of its development, but may be subject to change.

Expert opinion on the SOUL study results